- VXRT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-8 Filing
Vaxart (VXRT) S-8Registration of securities for employees
Filed: 3 Jul 24, 6:02am
Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Vaxart, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
Equity | Common Stock | Other | 16,800,000(1) | $0.6552(2) | $11,007,360(1)(2) | 0.00014760 | $1,625 |
Total Offering Amounts | $11,007,360 | $1,625 | |||||
Total Fee Offsets | $0 | ||||||
Net Fee Due | $1,625 |
(1) | Consists of shares of Vaxart, Inc.’s (the “Registrant”) common stock, par value $0.0001 (“Common Stock”), not previously registered, consisting of (1) 15,000,000 shares of Common Stock that are issuable at any time or from time to time under the Registrant’s 2019 Equity Incentive Plan (as amended to date, the “Incentive Plan”), and (2) 1,800,000 shares of Common Stock that are issuable at any time or from time to time under the Registrant’s 2022 Employee Stock Purchase Plan (as amended to date, the “ESPP”). Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, (the “Securities Act”), this Registration Statement shall also cover any additional shares of Registrant’s Common Stock that become issuable under the Incentive Plan or the ESPP by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Registrant’s Common Stock, as applicable. | |
(2) | Estimated in accordance with Rules 457(c) and 457(h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $0.6552 per share, the average of the high and low prices of the Registrant’s Common Stock as reported on The Nasdaq Capital Market on June 28, 2024. |